178 related articles for article (PubMed ID: 19774471)
1. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.
Tsilidis KK; Brancati FL; Pollak MN; Rifai N; Clipp SL; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
Cancer Causes Control; 2010 Jan; 21(1):1-10. PubMed ID: 19774471
[TBL] [Abstract][Full Text] [Related]
2. Association of markers of insulin and glucose control with subsequent colorectal cancer risk.
Saydah SH; Platz EA; Rifai N; Pollak MN; Brancati FL; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):412-8. PubMed ID: 12750235
[TBL] [Abstract][Full Text] [Related]
3. Association of colorectal adenoma with components of metabolic syndrome.
Kim BC; Shin A; Hong CW; Sohn DK; Han KS; Ryu KH; Park BJ; Nam JH; Park JW; Chang HJ; Choi HS; Kim J; Oh JH
Cancer Causes Control; 2012 May; 23(5):727-35. PubMed ID: 22450737
[TBL] [Abstract][Full Text] [Related]
4. Distinct Metabolic Profiles are Associated with Colorectal Adenomas and Serrated Polyps.
Fliss-Isakov N; Zelber-Sagi S; Webb M; Halpern Z; Shibolet O; Kariv R
Obesity (Silver Spring); 2017 Nov; 25 Suppl 2():S72-S80. PubMed ID: 29086511
[TBL] [Abstract][Full Text] [Related]
5. [Association of colorectal adenoma and metabolic syndrome and relevant parameters].
Liu Z; Hu X; Cui S; Gu J; Joe King Man F; Fion Siu Yin C; Peng J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):675-9. PubMed ID: 27353103
[TBL] [Abstract][Full Text] [Related]
6. Association between markers of glucose metabolism and risk of colorectal adenoma.
Rampal S; Yang MH; Sung J; Son HJ; Choi YH; Lee JH; Kim YH; Chang DK; Rhee PL; Rhee JC; Guallar E; Cho J
Gastroenterology; 2014 Jul; 147(1):78-87.e3. PubMed ID: 24632359
[TBL] [Abstract][Full Text] [Related]
7. Impaired Secretion of Glucagon-Like Peptide 1 in Patients with Colorectal Adenoma after an Oral Glucose Load.
Sasaki Y; Abe Y; Takeda H; Nishise S; Yaoita T; Yagi M; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kawata S; Ueno Y
Digestion; 2018; 97(4):324-332. PubMed ID: 29539609
[TBL] [Abstract][Full Text] [Related]
8. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.
Kang HW; Kim D; Kim HJ; Kim CH; Kim YS; Park MJ; Kim JS; Cho SH; Sung MW; Jung HC; Lee HS; Song IS
Am J Gastroenterol; 2010 Jan; 105(1):178-87. PubMed ID: 19755965
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas.
Rollison DE; Helzlsouer KJ; Lee JH; Fulp W; Clipp S; Hoffman-Bolton JA; Giuliano AR; Platz EA; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1515-23. PubMed ID: 19383887
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and colorectal neoplasms: An ominous association.
Trabulo D; Ribeiro S; Martins C; Teixeira C; Cardoso C; Mangualde J; Freire R; Gamito É; Alves AL; Augusto F; Oliveira AP; Cremers I
World J Gastroenterol; 2015 May; 21(17):5320-7. PubMed ID: 25954106
[TBL] [Abstract][Full Text] [Related]
11. Obesity-related parameters and colorectal adenoma development.
Kim TJ; Kim JE; Choi YH; Hong SN; Kim YH; Chang DK; Rhee PL; Kim MJ; Jung SH; Son HJ
J Gastroenterol; 2017 Dec; 52(12):1221-1229. PubMed ID: 28197803
[TBL] [Abstract][Full Text] [Related]
12. Association of body fat distribution and metabolic syndrome with the occurrence of colorectal adenoma: A case-control study.
Liu ZH; Zhang GX; Zhang H; Jiang L; Deng Y; Chan FSY; Fan JKM
J Dig Dis; 2021 Apr; 22(4):222-229. PubMed ID: 33656773
[TBL] [Abstract][Full Text] [Related]
13. Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus.
Yang YX; Habel LA; Capra AM; Achacoso NS; Quesenberry CP; Ferrara A; Levin TR; Lewis JD
Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3027-36. PubMed ID: 20937982
[TBL] [Abstract][Full Text] [Related]
14. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
[TBL] [Abstract][Full Text] [Related]
15. Fat, fiber, fruits, vegetables, and risk of colorectal adenomas.
Mathew A; Peters U; Chatterjee N; Kulldorff M; Sinha R
Int J Cancer; 2004 Jan; 108(2):287-92. PubMed ID: 14639617
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome, lifestyle risk factors, and distal colon adenoma: a retrospective cohort study.
Kim MC; Kim CS; Chung TH; Park HO; Yoo CI
World J Gastroenterol; 2011 Sep; 17(35):4031-7. PubMed ID: 22046093
[TBL] [Abstract][Full Text] [Related]
17. Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study.
Botma A; Nagengast FM; Braem MG; Hendriks JC; Kleibeuker JH; Vasen HF; Kampman E
J Clin Oncol; 2010 Oct; 28(28):4346-53. PubMed ID: 20733131
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and colorectal adenoma in the CLUE II cohort.
Tsilidis KK; Erlinger TP; Rifai N; Hoffman S; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
Cancer Causes Control; 2008 Aug; 19(6):559-67. PubMed ID: 18214695
[TBL] [Abstract][Full Text] [Related]
19. Insights into insulin resistance, lifestyle, and anthropometric measures of patients with prior colorectal cancer compared to controls: A National Health and Nutrition Examination Survey (NHANES) Study.
Obi K; Ramsey M; Hinton A; Stanich P; Gray DM; Krishna SG; El-Dika S; Hussan H
Curr Probl Cancer; 2018; 42(2):276-285. PubMed ID: 29395416
[TBL] [Abstract][Full Text] [Related]
20. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study.
Morita T; Tabata S; Mineshita M; Mizoue T; Moore MA; Kono S
Asian Pac J Cancer Prev; 2005; 6(4):485-9. PubMed ID: 16435997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
